-transparent.png){kind=logo}
The pharmacokinetics of ifosfamide and some metabolites in children was investigated. The patients received various doses of ifosfamide, mostly by continuous infusion, over several days. The penetration of ifosfamide and its metabolites into the cerebrospinal fluid was also studied in four cases. Ifosfamide and 4-hydroxyifosfamide pass the blood-brain barrier, reaching cerebrospinal fluid concentrations that are almost as high as plasma concentrations.
Related Publications
G P Kaijser, and
J De Kraker, and
A Bult, and
W J Underberg, and
J H Beijnen
January 1994,
Cancer chemotherapy and pharmacology,
G P Kaijser, and
J De Kraker, and
A Bult, and
W J Underberg, and
J H Beijnen
January 2001,
Clinical pharmacokinetics,
G P Kaijser, and
J De Kraker, and
A Bult, and
W J Underberg, and
J H Beijnen
July 2001,
Drug metabolism and disposition: the biological fate of chemicals,
G P Kaijser, and
J De Kraker, and
A Bult, and
W J Underberg, and
J H Beijnen
November 1997,
Clinical cancer research : an official journal of the American Association for Cancer Research,
G P Kaijser, and
J De Kraker, and
A Bult, and
W J Underberg, and
J H Beijnen
January 2001,
Clinical pharmacokinetics,
G P Kaijser, and
J De Kraker, and
A Bult, and
W J Underberg, and
J H Beijnen
November 1991,
Investigational new drugs,
G P Kaijser, and
J De Kraker, and
A Bult, and
W J Underberg, and
J H Beijnen
August 1976,
Journal of pharmacokinetics and biopharmaceutics,
G P Kaijser, and
J De Kraker, and
A Bult, and
W J Underberg, and
J H Beijnen
April 1975,
Clinical pharmacology and therapeutics,
G P Kaijser, and
J De Kraker, and
A Bult, and
W J Underberg, and
J H Beijnen
January 1990,
Lancet (London, England),
G P Kaijser, and
J De Kraker, and
A Bult, and
W J Underberg, and
J H Beijnen
June 1994,
Clinical pharmacokinetics,
